MX2020013811A - Compuestos. - Google Patents
Compuestos.Info
- Publication number
- MX2020013811A MX2020013811A MX2020013811A MX2020013811A MX2020013811A MX 2020013811 A MX2020013811 A MX 2020013811A MX 2020013811 A MX2020013811 A MX 2020013811A MX 2020013811 A MX2020013811 A MX 2020013811A MX 2020013811 A MX2020013811 A MX 2020013811A
- Authority
- MX
- Mexico
- Prior art keywords
- formula
- compounds
- hydrogen
- treatment
- methods
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/50—Cyclic peptides containing at least one abnormal peptide link
- C07K7/54—Cyclic peptides containing at least one abnormal peptide link with at least one abnormal peptide link in the ring
- C07K7/60—Cyclic peptides containing at least one abnormal peptide link with at least one abnormal peptide link in the ring the cyclisation occurring through the 4-amino group of 2,4-diamino-butanoic acid
- C07K7/62—Polymyxins; Related peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Epidemiology (AREA)
- Gastroenterology & Hepatology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862689602P | 2018-06-25 | 2018-06-25 | |
| PCT/EP2019/066819 WO2020002325A1 (en) | 2018-06-25 | 2019-06-25 | Compounds |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MX2020013811A true MX2020013811A (es) | 2021-03-09 |
Family
ID=67107423
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2020013811A MX2020013811A (es) | 2018-06-25 | 2019-06-25 | Compuestos. |
Country Status (31)
| Country | Link |
|---|---|
| US (3) | US11459357B2 (enExample) |
| EP (2) | EP3810633B1 (enExample) |
| JP (2) | JP7488774B2 (enExample) |
| KR (1) | KR20210054500A (enExample) |
| CN (2) | CN118878638A (enExample) |
| AR (1) | AR116663A1 (enExample) |
| AU (2) | AU2019294261B2 (enExample) |
| BR (1) | BR112020026663A2 (enExample) |
| CA (1) | CA3103158A1 (enExample) |
| CO (1) | CO2020016080A2 (enExample) |
| DK (1) | DK3810633T3 (enExample) |
| EA (1) | EA202092819A1 (enExample) |
| ES (1) | ES2971732T3 (enExample) |
| FI (1) | FI3810633T3 (enExample) |
| HR (1) | HRP20240028T1 (enExample) |
| HU (1) | HUE065134T2 (enExample) |
| IL (2) | IL279620B2 (enExample) |
| LT (1) | LT3810633T (enExample) |
| MA (1) | MA52946B1 (enExample) |
| MD (1) | MD3810633T2 (enExample) |
| MX (1) | MX2020013811A (enExample) |
| PH (1) | PH12020552240A1 (enExample) |
| PL (1) | PL3810633T3 (enExample) |
| PT (1) | PT3810633T (enExample) |
| RS (1) | RS65128B1 (enExample) |
| SG (1) | SG11202012747VA (enExample) |
| SI (1) | SI3810633T1 (enExample) |
| TW (2) | TWI851584B (enExample) |
| UA (1) | UA128162C2 (enExample) |
| WO (1) | WO2020002325A1 (enExample) |
| ZA (1) | ZA202301937B (enExample) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN107108699A (zh) | 2014-11-26 | 2017-08-29 | 新药物许可控股有限公司 | 化合物 |
| DK3810633T3 (da) * | 2018-06-25 | 2024-01-15 | Spero Therapeutics Inc | Forbindelser |
| TW202233649A (zh) | 2020-11-06 | 2022-09-01 | 美商斯佩羅治療學股份有限公司 | 化合物 |
| WO2022262823A1 (zh) * | 2021-06-18 | 2022-12-22 | 华南理工大学 | 活性氧自由基响应的多粘菌素前药化合物及其应用 |
| CN120574287B (zh) * | 2025-06-10 | 2026-07-03 | 中国药科大学 | 一种抗菌肽、组合物及应用 |
| CN121159640A (zh) * | 2025-07-24 | 2025-12-19 | 中国药科大学 | 一种抗菌肽、药物组合物及应用 |
| CN120699105B (zh) * | 2025-08-19 | 2025-11-21 | 中国药科大学 | 一种氘代抗菌肽及其组合物和应用 |
Family Cites Families (30)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB2128617A (en) | 1982-10-06 | 1984-05-02 | Martti Vaara | Polypeptides for use in antibacterial therapy |
| AU7753787A (en) | 1986-08-06 | 1988-02-24 | Jean-Luc Fauchere | Production of covalent-linked conjugates from an antibiotic and a non-toxic derivative of polymyxine b |
| US20010021697A1 (en) | 1987-09-14 | 2001-09-13 | Henning Lowenstein | Methods and compositions for the treatment of mammalian infections employing medicaments comprising hymenoptera venom, proteinageous or polypeptide components thereof, or analogues of such proteinaceous or polypeptide components |
| TW274552B (enExample) | 1992-05-26 | 1996-04-21 | Hoechst Ag | |
| US5767068A (en) | 1997-02-13 | 1998-06-16 | Pathogenesis Corporation | Pure biologically active colistin, its components and a colistin formulation for treatment of pulmonary infections |
| JP2007507512A (ja) | 2003-09-30 | 2007-03-29 | コーヒ コーポレーション | 熱傷を治療するための組成物および方法 |
| US20060004185A1 (en) | 2004-07-01 | 2006-01-05 | Leese Richard A | Peptide antibiotics and peptide intermediates for their prepartion |
| BRPI0715095B8 (pt) | 2006-08-11 | 2021-05-25 | Northern Antibiotics Oy | derivado de polimixina da fórmula geral (i); produto de combinação; composição farmacêutica; método para se sensibilizar bactérias gram-negativas a um agente antibacteriano; método para o desenvolvimento de antibióticos; método para a redução da toxicidade de polimixinas, octapeptinas naturais e seus derivados durante a aplicação das mesmas no tratamento de infecções em um indivíduo; método para melhorar as propriedades farmacocinéticas, de polimixinas, octapeptinas naturais e seus derivados; método para a sensibilização de bactérias gram-negativas clinicamente importantes a um complemento de mecanismo de defesa presente no soro; uso de um derivado; e processo para a preparação de um derivado de polimixina da fórmula (i). |
| US7807637B2 (en) | 2006-08-11 | 2010-10-05 | Northern Antibiotics Oy | Polymyxin derivatives and uses thereof |
| US8329645B2 (en) | 2008-02-08 | 2012-12-11 | Northern Antibiotics Ltd. | Polymyxin derivatives and uses thereof |
| US8193148B2 (en) | 2008-02-08 | 2012-06-05 | Northern Antibiotics Ltd. | Short fatty acid tail polymyxin derivatives and uses thereof |
| FI20085469A0 (fi) | 2008-02-08 | 2008-05-16 | Northern Antibiotics Oy | Polymyksiinijohdannaiset, joissa on lyhyt rasvahappohäntä, ja niiden käyttöjä |
| ES2334547B1 (es) | 2008-09-10 | 2010-12-03 | Universidad De Barcelona | Compuestos peptidicos antibacterianos. |
| WO2010075416A1 (en) | 2008-12-23 | 2010-07-01 | Biosource Pharm, Inc. | Antibiotic compositions for the treatment of gram negative infections |
| CN101851270A (zh) | 2009-04-03 | 2010-10-06 | 梁浩 | 一种多粘菌素衍生物及其制备方法 |
| WO2010130007A1 (en) | 2009-05-14 | 2010-11-18 | Monash University | Antimicrobial compounds |
| US8415307B1 (en) | 2010-06-23 | 2013-04-09 | Biosource Pharm, Inc. | Antibiotic compositions for the treatment of gram negative infections |
| WO2012051663A1 (en) | 2010-10-21 | 2012-04-26 | Monash University | Antimicrobial compounds |
| WO2012168820A1 (en) * | 2011-06-08 | 2012-12-13 | Pfizer Inc. | Polymyxin derivatives useful as antibacterial agents |
| MX355217B (es) | 2011-11-18 | 2018-04-10 | New Pharma Licence Holdings Ltd | Derivados de polimixina. |
| HUE059544T2 (hu) | 2013-05-22 | 2022-11-28 | Spero Therapeutics Inc | Polimixin-származékok és ezek alkalmazása kombinációs terápiában különbözõ antibiotikumokkal |
| KR20160135739A (ko) * | 2014-03-11 | 2016-11-28 | 뉴 파마 라이센스 홀딩스 리미티드 | 폴리믹신 유도체 및 상이한 항생제와의 조합 요법에 있어서의 이들의 용도 |
| US10047126B2 (en) | 2014-04-01 | 2018-08-14 | Monash University | Polymyxin derivatives as antimicrobial compounds |
| CN107108699A (zh) | 2014-11-26 | 2017-08-29 | 新药物许可控股有限公司 | 化合物 |
| BR112017010888A2 (pt) * | 2014-12-17 | 2018-02-27 | Hoffmann La Roche | método para produzir um produto de conjugação enzimática de três polipeptídeos |
| WO2016166103A1 (en) * | 2015-04-13 | 2016-10-20 | Xellia Pharmaceuticals Aps | Polymyxin derivatives |
| JP7367950B2 (ja) * | 2015-09-29 | 2023-10-24 | モナッシュ ユニバーシティ | 抗菌性ポリミキシン誘導体化合物 |
| US10428122B2 (en) * | 2016-06-16 | 2019-10-01 | International Aids Vaccine Initiative, Inc. | Tuberculosis compositions and methods of treating or preventing tuberculosis |
| DK3810633T3 (da) * | 2018-06-25 | 2024-01-15 | Spero Therapeutics Inc | Forbindelser |
| WO2020014501A1 (en) | 2018-07-11 | 2020-01-16 | Cidara Therapeutics, Inc. | Compositions and methods for the treatment of bacterial infections |
-
2019
- 2019-06-25 DK DK19734346.0T patent/DK3810633T3/da active
- 2019-06-25 EP EP19734346.0A patent/EP3810633B1/en active Active
- 2019-06-25 EP EP23215457.5A patent/EP4316504A3/en active Pending
- 2019-06-25 ES ES19734346T patent/ES2971732T3/es active Active
- 2019-06-25 AU AU2019294261A patent/AU2019294261B2/en active Active
- 2019-06-25 EA EA202092819A patent/EA202092819A1/ru unknown
- 2019-06-25 RS RS20240128A patent/RS65128B1/sr unknown
- 2019-06-25 TW TW108122117A patent/TWI851584B/zh active
- 2019-06-25 BR BR112020026663-9A patent/BR112020026663A2/pt not_active Application Discontinuation
- 2019-06-25 CN CN202410703525.5A patent/CN118878638A/zh active Pending
- 2019-06-25 LT LTEPPCT/EP2019/066819T patent/LT3810633T/lt unknown
- 2019-06-25 CN CN201980041706.3A patent/CN112789287B/zh active Active
- 2019-06-25 MA MA52946A patent/MA52946B1/fr unknown
- 2019-06-25 US US17/253,426 patent/US11459357B2/en active Active
- 2019-06-25 AR ARP190101764A patent/AR116663A1/es unknown
- 2019-06-25 UA UAA202008220A patent/UA128162C2/uk unknown
- 2019-06-25 IL IL279620A patent/IL279620B2/en unknown
- 2019-06-25 FI FIEP19734346.0T patent/FI3810633T3/fi active
- 2019-06-25 PT PT197343460T patent/PT3810633T/pt unknown
- 2019-06-25 CA CA3103158A patent/CA3103158A1/en active Pending
- 2019-06-25 MD MDE20210390T patent/MD3810633T2/ro unknown
- 2019-06-25 IL IL323560A patent/IL323560A/en unknown
- 2019-06-25 PL PL19734346.0T patent/PL3810633T3/pl unknown
- 2019-06-25 HR HRP20240028TT patent/HRP20240028T1/hr unknown
- 2019-06-25 MX MX2020013811A patent/MX2020013811A/es unknown
- 2019-06-25 WO PCT/EP2019/066819 patent/WO2020002325A1/en not_active Ceased
- 2019-06-25 TW TW113126533A patent/TW202446783A/zh unknown
- 2019-06-25 KR KR1020217000402A patent/KR20210054500A/ko active Pending
- 2019-06-25 HU HUE19734346A patent/HUE065134T2/hu unknown
- 2019-06-25 SI SI201930707T patent/SI3810633T1/sl unknown
- 2019-06-25 JP JP2020571762A patent/JP7488774B2/ja active Active
- 2019-06-25 SG SG11202012747VA patent/SG11202012747VA/en unknown
-
2020
- 2020-12-21 PH PH12020552240A patent/PH12020552240A1/en unknown
- 2020-12-22 CO CONC2020/0016080A patent/CO2020016080A2/es unknown
-
2022
- 2022-08-23 US US17/893,944 patent/US12528837B2/en active Active
-
2023
- 2023-02-06 ZA ZA2023/01937A patent/ZA202301937B/en unknown
-
2024
- 2024-05-10 JP JP2024077064A patent/JP2024109664A/ja not_active Ceased
- 2024-05-21 AU AU2024203362A patent/AU2024203362A1/en active Pending
-
2025
- 2025-12-10 US US19/415,229 patent/US20260103491A1/en active Pending
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CO2020016080A2 (es) | Compuestos | |
| CL2020003007A1 (es) | Lactamas biciclicas y metodos de uso de las mismas (divisional solicitud no. 3486-2017) | |
| CO2019000386A2 (es) | Compuestos heterocíclicos como inmunomoduladores | |
| CO2019009373A2 (es) | Compuestos heterocíclicos útiles como inhibidores duales de atx/ca. | |
| MX2022012313A (es) | Oxisteroles y metodos de uso de los mismos. | |
| UY35617A (es) | Inhibidores de la fosfatidilinositol 3-quinasa | |
| ECSP17002135A (es) | Compuestos antiproliferativos y métodos de uso de los mismos | |
| MX2017002656A (es) | Compuestos que inhiben la proteína mcl-1. | |
| CL2019001495A1 (es) | Compuestos de heterociclo tetracíclicos útiles como inhibidores de la integrasa del vih. | |
| MX2018012544A (es) | Nuevos derivados de pirazolopirimidina. | |
| CU20160109A7 (es) | Compuestos de indazol como inhibidores de irak4 | |
| UY35242A (es) | Inhibidores de fosfatidilinositol 3-quinasa | |
| PE20210470A1 (es) | Macrociclos con grupos p2' heterociclicos como inhibidores del factor xia | |
| MX2017004600A (es) | Compuestos de aminopurina sustituida, composiciones del mismo, y metodos de tratamiento con los mismos. | |
| MX2018007333A (es) | Compuestos heteroaromaticos como inhibidores de btk. | |
| MX2021005535A (es) | Compuestos antibióticos, métodos de fabricacion de los mismos, composiciones farmacéuticas contienendo los mismos y usos de los mismos. | |
| AR125457A2 (es) | Compuestos inhibidores dobles de magl y faah y composición farmacéutica | |
| CL2020000944A1 (es) | Compuestos bicíclicos y métodos de utilización de los mismos. | |
| CU20170089A7 (es) | Derivados de quinazolina utilizados para tratar el vih | |
| DOP2020000100A (es) | Novedosos derivados de pirazolo-pirrolo-pirimidina como inhibidores de p2x3 | |
| CL2020001062A1 (es) | Sulfonas y sulfóxidos bicíclicos y métodos de uso de los mismos. | |
| CO2022009260A2 (es) | Composiciones farmacéuticas oftálmicas | |
| MX2017012238A (es) | Inhibidores de la polimerasa del virus de la hepatitis c. | |
| ECSP21011232A (es) | Nuevo derivado de amina heterocíclico y composición farmacéutica que lo comprende | |
| MX2019014192A (es) | Inhibidor de inmunosupresion asociado al cancer. |